Programmed cell death 4 and microRNA 21 inverse expression is maintained in cells and exosomes from ovarian serous carcinoma effusions

The inhibition of miR-21 promotes apoptosis and chemosensitivity in ovarian cancer

(2014) John K. Chan et al.   GYNECOLOGIC ONCOLOGY

Berberine sensitizes ovarian cancer cells to cisplatin through miR-21/PDCD4 axis

(2013) S. Liu et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Exosomes

(2013) Huang-Ge Zhang et al.   AMERICAN JOURNAL OF PATHOLOGY

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears

(2013) Ambrogio Fassina et al.   CANCER CYTOPATHOLOGY

Detection of MicroRNAs in Archival Cytology Urine Smears

(2013) Francesca Simonato et al.   PLoS One

Protein Kinase CK2 Inhibition Down Modulates the NF-κB and STAT3 Survival Pathways, Enhances the Cellular Proteotoxic Stress and Synergistically Boosts the Cytotoxic Effect of Bortezomib on Multiple Myeloma and Mantle Cell Lymphoma Cells

(2013) Sabrina Manni et al.   PLoS One

Tumor-cell-derived microvesicles as carriers of molecular information in cancer

(2012) Vilma R. Martins et al.   CURRENT OPINION IN ONCOLOGY

Neoadjuvant chemotherapy, interval debulking surgery or primary surgery in ovarian carcinoma FIGO stage IV?

(2012) Claes G. Tropé et al.   EUROPEAN JOURNAL OF CANCER

The miR-17-92 microRNA cluster: a novel diagnostic tool in large B-cell malignancies

(2012) Ambrogio Fassina et al.   LABORATORY INVESTIGATION

Survivin expression impacts prognostically on NSCLC but not SCLC

(2012) Antonio Rosato et al.   LUNG CANCER

Tumour Suppressive Function and Modulation of Programmed Cell Death 4 (PDCD4) in Ovarian Cancer

(2012) Na Wei et al.   PLoS One

PDCD4 expression in thyroid neoplasia

(2012) Gianmaria Pennelli et al.   VIRCHOWS ARCHIV

Classification of Non-small Cell Lung Carcinoma in Transthoracic Needle Specimens Using MicroRNA Expression Profiling

(2011) Ambrogio Fassina et al.   CHEST

Intercellular nanovesicle-mediated microRNA transfer: A mechanism of environmental modulation of hepatocellular cancer cell growth

(2011) Takayuki Kogure et al.   HEPATOLOGY

Neoadjuvant Chemotherapy Is the Better Treatment Option in Some Patients With Stage IIIc to IV Ovarian Cancer

(2011) Ignace Vergote et al.   JOURNAL OF CLINICAL ONCOLOGY

Epithelial–mesenchymal transition in malignant mesothelioma

(2011) Ambrogio Fassina et al.   MODERN PATHOLOGY

PDCD4 nuclear loss inversely correlates with miR-21 levels in colon carcinogenesis

(2011) Matteo Fassan et al.   VIRCHOWS ARCHIV

Programmed cell death 4 enhances chemosensitivity of ovarian cancer cells by activating death receptor pathway in vitro and in vivo

(2010) Xia Zhang et al.   CANCER SCIENCE

Secreted Monocytic miR-150 Enhances Targeted Endothelial Cell Migration

(2010) Yujing Zhang et al.   MOLECULAR CELL

Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer

(2010) Ignace Vergote et al.   NEW ENGLAND JOURNAL OF MEDICINE

Let-7 MicroRNA Family Is Selectively Secreted into the Extracellular Environment via Exosomes in a Metastatic Gastric Cancer Cell Line

(2010) Keiichi Ohshima et al.   PLoS One

Functional delivery of viral miRNAs via exosomes

(2010) D. M. Pegtel et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

PDCD4 inhibits the malignant phenotype of ovarian cancer cells

(2009) Zeng-Tao Wei et al.   CANCER SCIENCE

Loss of Programmed cell death 4 (Pdcd4) associates with the progression of ovarian cancer

(2009) Na Wei et al.   Molecular Cancer

MicroRNA Expression Profiles in Serous Ovarian Carcinoma

(2008) E. J. Nam et al.   CLINICAL CANCER RESEARCH

MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer

(2008) Douglas D. Taylor et al.   GYNECOLOGIC ONCOLOGY